Berberine decreases PCSK9 expression in HepG2 cells-Reference-Cited by-同舟云学术

Berberine decreases PCSK9 expression in HepG2 cells

Published:2008-12 Issue:2 Volume:201 Page:266-273
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Cameron Jamie,Ranheim Trine,Kulseth Mari Ann,Leren Trond P.,Berge Knut Erik

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Mortality and coronary heart disease among men studied for 23 years;Keys;Arch Intern Med,1971

2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);The Scandinavian Simvastatin Survival Study Group;Lancet,1994

3. Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia;Dubuc;Arterioscler Thromb Vasc Biol,2004

4. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia;Abifadel;Nat Genet,2003

5. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat a of low density lipoprotein receptor decreases receptor recycling and increases degradation;Zhang;J Biol Chem,2007

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease;Current Reviews in Clinical and Experimental Pharmacology;2024-11

2. Natural phytochemicals as small-molecule proprotein convertase subtilisin/kexin type 9 inhibitors;Tzu Chi Medical Journal;2024-09-05

3. The role of natural products as PCSK9 modulators: A review;Phytotherapy Research;2024-06-20

4. Understanding the Relationship Between Cerebrovascular Disease and the Gut Microbiome;Stroke: Vascular and Interventional Neurology;2024-06-20

5. Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies;Frontiers in Pharmacology;2024-06-18